Latest ARCH VENTURE CORP Stock Portfolio

$80.28Million

Equity Portfolio Value

Last Reported on: 15 May, 2024

About ARCH VENTURE CORP and it’s 13F Hedge Fund Stock Holdings

In it's latest 13F Holdings report, ARCH Venture Management, LLC reported an equity portfolio of $80.3 Millions as of 31 Mar, 2024.

The top stock holdings of ARCH Venture Management, LLC are VERV, ERAS, GOSS. The fund has invested 33.2% of it's portfolio in VERVE THERAPEUTICS, INC. and 28.4% of portfolio in ERASCA, INC.

The fund managers got completely rid off REVOLUTION MEDICINES, INC. (RVMD) stocks. ARCH Venture Management, LLC opened new stock positions in Q32 BIO INC. and CERO THERAPEUTICS HOLDINGS, INC. (PBAX).

New Buys

Ticker	$ Bought
Q32 BIO INC.	5,461,010
CERO THERAPEUTICS HOLDINGS, INC.	4,433,990

New stocks bought by ARCH VENTURE CORP

Additions

No additions were made to existing positions by ARCH VENTURE CORP

Reductions

None of the existing positions were reduced by ARCH VENTURE CORP

Sold off

Ticker	$ Sold
REVOLUTION MEDICINES, INC.	-92,736,500

ARCH VENTURE CORP got rid off the above stocks

Current Stock Holdings of ARCH VENTURE CORP

Last Reported on: 15 May, 2024

Ticker	Namesorted ascending	% Portfolio	Shares Held	$ Value	Type	% Change
DNLI	DENALI THERAPEUTICS, INC.	9.74	381,249	7,823,230	UNCHANGED	0.00
ERAS	ERASCA, INC.	28.37	11,055,600	22,774,400	UNCHANGED	0.00
GOSS	GOSSAMER BIO, INC.	11.84	8,055,920	9,505,980	UNCHANGED	0.00
OMIC	SINGULAR GENOMICS SYSTEMS, INC.	2.43	3,798,930	1,953,410	UNCHANGED	0.00
PBAX	CERO THERAPEUTICS HOLDINGS, INC.	5.52	1,444,300	4,433,990	NEW
RVMD	REVOLUTION MEDICINES, INC.	0.00	0.00	0.00	SOLD OFF	-100
UBX	UNITY BIOTECHNOLOGY, INC.	2.05	1,004,820	1,647,900	UNCHANGED	0.00
VERV	VERVE THERAPEUTICS, INC.	33.23	2,008,810	26,677,000	UNCHANGED	0.00
	Q32 BIO INC.	6.80	320,482	5,461,010	NEW